Emergence of TEM, SHV, and CTX-M-Extended Spectrum β-Lactamases and Class 1 Integron Among Enterobacter cloacae Isolates Collected from Hospitals of …

A Peymani, TN Farivar, R Sanikhani… - Microbial Drug …, 2014 - liebertpub.com
Extended-spectrum β-lactamase (ESBL) production is an important resistance mechanism
among clinical isolates of Enterobacter cloacae. TEM, SHV, and CTX-M are the most …

Characterization and Molecular Epidemiology of Extended Spectrum Beta-Lactamase Producing Enterobacter cloacae Isolated from a Tunisian Hospital

S Hammami, IBB Boubaker, M Saidani… - Microbial Drug …, 2012 - liebertpub.com
In 2009, out of the 66 nonrepetitive Enterobacter cloacae collected at Charles Nicolle
hospital in Tunisia, 44 were extended spectrum β-lactamase (ESBL) producers. The aim of …

Survey of Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacter cloacae Isolates in a Chinese Tertiary Hospital, 2012–2014

XL Cao, L Cheng, ZF Zhang, MZ Ning… - Microbial Drug …, 2017 - liebertpub.com
A total of 72 consecutive and nonduplicate clinical extended-spectrum β-lactamase (ESBL)-
producing Enterobacter cloacae isolates were collected from our hospital from 2012 to 2014 …

Class 1 integrons contributes to antibiotic resistance among clinical isolates of Escherichia coli producing extended-spectrum beta-lactamases

T Chen, Y Feng, JL Yuan, Y Qi, YX Cao… - Indian journal of medical …, 2013 - Elsevier
Objectives: The objective of this study is to determine the prevalence of antibiotic resistance
factors, including the production of extended-spectrum beta-lactamases (ESBLs) and the …

Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens …

RD Markovska, TJ Stoeva, KD Bojkova… - Microbial Drug …, 2014 - liebertpub.com
Forty-two extended-spectrum beta-lactamase (ESBL)-producing isolates of Enterobacter
aerogenes, Enterobacter cloacae, Pantoea agglomerans, and Serratia marcescens …

Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria

S Nedjai, A Barguigua, N Djahmi, L Jamali… - The Journal of Infection …, 2013 - jidc.org
Introduction: Expended spectrum β-lactamase (ESBL)-producing Enterobacter cloacae is an
important nosocomial pathogen. In this study, the prevalence and the molecular …

Molecular typing and characterization of TEM, SHV, CTX-M, and CMY-2 β-lactamases in Enterobacter cloacae strains isolated in patients and their hospital …

D Souna, AS Amir, SN Bekhoucha, M Berrazeg… - Medecine et maladies …, 2014 - Elsevier
Objectives Enterobacter cloacae is a major nosocomial bacterium causing severe infections.
A multicenter retrospective cohort study was conducted to collect baseline information on the …

Characterisation and molecular epidemiology of extended‐spectrum β‐lactamase‐producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan

WL Yu, KC Cheng, CJ Chi, HE Chen… - Clinical microbiology …, 2006 - Wiley Online Library
Abstract Enterobacter cloacae (n= 110) isolates from a district hospital in Taiwan were
screened for extended‐spectrum β‐lactamases (ESBLs). In total, 17 ESBL‐producers were …

Enterobacter cloacae Complex and CTX-M Extended-Spectrum β-Lactamases in Algeria

D Souna, M Drissi, I Almahmoud… - Microbial Drug …, 2022 - liebertpub.com
We evaluated the β-lactam resistance phenotypes of clinical and environmental strains of
the Enterobacter cloacae complex (ECC) isolated from three Algerian hospitals. The first …

Phenotypic and genotypic characterization of multidrug resistant and extended-spectrum β-lactamase-producing Enterobacterales isolated from clinical samples in …

OA Nkengkana, RC Founou, LL Founou… - BMC Infectious …, 2023 - Springer
Abstract Background The 2017 World Health Organization (WHO) report has listed extended-
spectrum β-lactamase-producing Enterobacterales (ESBL-E) as critical pathogens for public …